An adjunctive panel can be suggested, including CD10, EMA, cathepsin K, c-kit, HNF1β, and E-cadherin, following a primary screening panel of the CK7-CAIX-AMACR algorithm, which is the most efficient strategy for subtyping of RCC. The gene discussed is CA9; the disease is renal cell carcinoma.